NEW YORK (Reuters) – Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.
Jury says J&J must pay $8 billion in case over male breast growth linked to Risperdal
Website developed in accordance with Web Content Accessibility Guidelines 2.1.
If you encounter any issues while using this site, please contact us: 516.579.6500
If you encounter any issues while using this site, please contact us: 516.579.6500
